The Latest Breaking News from DWave

Shares of D-Wave Quantum Inc (NYSE:QBTS) are trading lower Wednesday afternoon, caught in a broader market downturn. The broader tech sector is facing headwinds from a Reuters report that the United States is considering new restrictions on exports to China involving U.S. software and technology. Here’s what investors need to…

D-Wave Quantum sold another of its massive Advantage2 systems, expanding its reach in Europe. But has adoption picked up enough to justify the major rally?

Can D-Wave Quantum reach the Street-high price target of $33 this year?

A critique of D-Wave Quantum Inc. (NYSE:QBTS), amplified by ‘Pharma Bro’ Martin Shkreli, is challenging the company’s viability, alleging its technology is a potential “dead-end.”

D-Wave Quantum Inc (NYSE:QBTS) shares hit to a new 52-week high on Friday. Shares of quantum-related stocks are trading higher on a report indicating the Trump administration plans an expansion of quantum strategy.

D-Wave's shares have plateaued after roughly doubling year-to-date; can its primary quantum system, Advantage2, continue to drive growth?

Shares of D-Wave Quantum Inc (NYSE:QBTS) shares are trading higher by some 35% over the past week, hitting a new all-time high Thursday morning. The recent rally is fueled by a combination of favorable macroeconomic conditions and developments from the company’s Qubits Japan 2025 conference.

Although the technology sector suffered some anxious trading following long stretches of upside, certain standout names — including Oracle Corp (NYSE:ORCL) and its blistering forward outlook — helped invigorate confidence in the ecosystem. As it turns out, the quantum computing space has been reading the memo, with the industry delivering…

Honeywell's quantum joint venture, Quantinuum, recently announced a big influx of cash from NVIDIA and others; what does this mean for rivals like D-Wave?